Adam Koppel resigned from the board of PTC Therapeutics Inc.
His decision was based on the need to focus on his principal work activities and not due to any disagreement with the company.
Discover more about S&P Global’s offerings
PTC Therapeutics director resigns
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Adam Koppel resigned from the board of PTC Therapeutics Inc.
His decision was based on the need to focus on his principal work activities and not due to any disagreement with the company.